The statistical analysis reveals that the DAT+ group had a significantly lower risk of falls compared to the Missed Diagnosis group, indicating the importance of early diagnosis and treatment of PD in reducing adverse outcomes. The gene discussed is SLC6A3; the disease is Parkinson disease.